Memorial Sloan-Kettering Cancer Center, USA.
Palliat Med. 2011 Jul;25(5):398-401. doi: 10.1177/0269216311400480.
There are currently two indicators, Morphine Consumption Data and the Pain Management Index, that have been widely used to assess the efficacy of cancer pain treatment. Both are based on the World Health Organization guidelines for cancer pain and both have limitations in their ability to assess the quality of pain care for cancer patients. The published studies that have used these methods all report that cancer pain is generally undertreated in a wide range of clinical settings and care models.
目前有两个指标,吗啡消耗量数据和疼痛管理指数,被广泛用于评估癌症疼痛治疗的效果。这两个指标都基于世界卫生组织的癌症疼痛指南,但都存在评估癌症患者疼痛护理质量的能力局限性。使用这些方法的已发表研究报告称,在广泛的临床环境和护理模式中,癌症疼痛通常治疗不足。